Comment on "Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium"
- PMID: 37599054
- DOI: 10.1016/j.jtho.2023.05.014
Comment on "Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium"
Comment in
-
Re: Response to Letter to the Editor "Respiratory and Cardiometabolic Comorbidities and Stage I-III Non-Small Cell Lung Cancer (NSCLC) Survival: A Pooled Analysis From the International Lung Cancer Consortium".J Thorac Oncol. 2023 Sep;18(9):e96-e97. doi: 10.1016/j.jtho.2023.06.003. J Thorac Oncol. 2023. PMID: 37599055 No abstract available.
Comment on
-
Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium.J Thorac Oncol. 2023 Mar;18(3):313-323. doi: 10.1016/j.jtho.2022.10.020. Epub 2022 Nov 15. J Thorac Oncol. 2023. PMID: 36396063 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
